[Osteoarticular tuberculosis: a diagnostic problem]. 1975

N Sliman, and J V Fowles, and R Morisset

UI MeSH Term Description Entries
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014394 Tuberculosis, Osteoarticular Tuberculosis of the bones or joints. Bone Tuberculosis,Joint Tuberculosis,Bone Tuberculoses,Joint Tuberculoses,Osteoarticular Tuberculoses,Osteoarticular Tuberculosis,Tuberculoses, Bone,Tuberculoses, Joint,Tuberculoses, Osteoarticular,Tuberculosis, Bone,Tuberculosis, Joint

Related Publications

N Sliman, and J V Fowles, and R Morisset
November 1951, El Dia medico,
N Sliman, and J V Fowles, and R Morisset
October 1954, Gruzlica (Warsaw, Poland : 1926),
N Sliman, and J V Fowles, and R Morisset
August 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
N Sliman, and J V Fowles, and R Morisset
January 1959, Giornale di medicina militare,
N Sliman, and J V Fowles, and R Morisset
January 1960, Problemy tuberkuleza,
N Sliman, and J V Fowles, and R Morisset
April 2018, Revue medicale de Liege,
N Sliman, and J V Fowles, and R Morisset
January 1952, Tuberkuloza,
N Sliman, and J V Fowles, and R Morisset
January 1960, Problemy tuberkuleza,
N Sliman, and J V Fowles, and R Morisset
October 1952, Bruxelles medical,
N Sliman, and J V Fowles, and R Morisset
January 2023, International journal of mycobacteriology,
Copied contents to your clipboard!